Next Century Growth Investors’s Boston Scientific BSX Stock Holding History

Next Century Growth Investors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,198	Closed	-$972K	–	115
2025 Q4	$972K	Sell	10,198 -9,046	-47%	-$887K	0.07%	119
2025 Q3	$1.88M	Sell	19,244 -35,251	-65%	-$3.65M	0.14%	120
2025 Q2	$5.85M	Buy	54,495 +36,926	+210%	+$3.74M	0.45%	76
2025 Q1	$1.77M	Sell	17,569 -2,853	-14%	-$287K	0.16%	114
2024 Q4	$1.82M	Sell	20,422 -22,800	-53%	-$2.01M	0.14%	118
2024 Q3	$3.62M	Buy	43,222 +10,433	+32%	+$822K	0.29%	93
2024 Q2	$2.53M	Sell	32,789 -92	-0.3%	-$6.73K	0.21%	103
2024 Q1	$2.25M	Buy	+32,881	New	+$2.11M	0.2%	106

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Next Century Growth Investors's BSX Position: Q1 2026 in Review

Next Century Growth Investors sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 10,198 shares — an estimated $972K sold.

Next Century Growth Investors first reported a position in BSX in Q1 2024 and held it in 8 quarters. The position peaked at $5.85M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Next Century Growth Investors reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Next Century Growth Investors sold 10,198 Boston Scientific shares in Q1 2026, an estimated $972K.
Next Century Growth Investors first reported a position in Boston Scientific in Q1 2024 and held it in 8 quarters.
Next Century Growth Investors's Boston Scientific position peaked at $5.85M in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Next Century Growth Investors's 13F filing for Q1 2026, filed 14 May 2026.